A randomized multicenter trial of cyclosporin and prednisolone versus cyclosporin, azathioprine, and prednisolone following primary living donor renal transplantation

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Transplant International

• Publication date

  1994-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1432-2277.1994.tb01292.xPMID 8060471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing

  2004cited by this paper
• On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation

  2004cited by this paper
• Day‐to‐day variability in azathioprine pharmacokinetics in renal transplant recipients

  1994cited by this paper
• Acute rejection episodes – Best predictor of long‐term primary cadaveric renal transplant survival

  1994cited by this paper
• THE IMPACT OF ACUTE REJECTION EPISODES ON LONG‐TERM GRAFT FUNCTION AND OUTCOME IN 1347 PRIMARY RENAL TRANSPLANTS TREATED BY 3 CYCLOSPORINE REGIMENS

  1993cited by this paper
• Large interindividual variability in bioavailability of azathioprine in renal transplant recipients

  1993cited by this paper
• Impact of donor age on living related donor kidney transplantation.

  1992cited by this paper
• Kidney Transplantation from Living Unrelated Donors

  1992cited by this paper
• A RANDOMIZED TRIAL OF CYCLOSPORINE AND PREDNISOLONE VERSUS CYCLOSPORINE, AZATHIOPRINE, AND PREDNISOLONE IN PRIMARY CADAVERIC RENAL TRANSPLANTATION

  1992cited by this paper
• Analysis of 22 years experience in living-related transplantation at the University of Alabama in Birmingham.

  1991cited by this paper
• A survey of vascular access for haemodialysis in The Netherlands.

  1991cited by this paper
• Combined report on regular dialysis and transplantation in Europe, XX, 1989.

  1991cited by this paper
• Synergism, how assessed and how achieved

  1991cited by this paper
• Unrelated living donor kidney transplantation

  1990cited by this paper
• Outcome of kidney transplantation in different diseases.

  1990cited by this paper
• Kidney transplantation from a spouse: an alternative to years of dialysis waiting for a graft that may never turn up?

  1990cited by this paper
• Influence of cadaver donor age on posttransplant renal function and graft outcome.

  1990cited by this paper
• Power and sample size calculations. A review and computer program.

  1990cited by this paper
• A RANDOMIZED TRIAL COMPARING DOUBLE‐DRUG AND TRIPLE‐DRUG THERAPY IN PRIMARY CADAVERIC RENAL TRANSPLANTS

  1990influential reference
• Outcome of kidney transplantation in different diseases.

  1990cited by this paper
• THE RISKS AND BENEFITS OF LOW‐DOSE COTRIMOXAZOLE PROPHYLAXIS FOR PNEUMOCYSTIS PNEUMONIA IN RENAL TRANSPLANTATION

  1989cited by this paper
• Cyclosporin A nephrotoxicity.

  1989cited by this paper
• Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation.

  1989cited by this paper
• Drug therapy: cyclosporine

  1989cited by this paper
• Cyclosporine.

  1989cited by this paper
• A RANDOMIZED TRIAL COMPARING TRIPLE‐DRUG AND DOUBLE‐DRUG THERAPY IN RENAL TRANSPLANTATION

  1988influential reference
• The influence of donor age on renal function in transplant recipients.

  1988cited by this paper
• High- and low-dose regimens of cyclosporin in renal transplantation: immunosuppressive efficacy and side-effects.

  1988cited by this paper
• The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.

  1987cited by this paper
• Causes of graft loss and mortality in cyclosporine-treated cadaveric kidney graft recipients.

  1987cited by this paper
• T cell subsets controlling graft-v-host disease in mice.

  1987cited by this paper
• Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.

  1987cited by this paper
• Renal transplantation from HLA‐haploidentical living related donors: The Scandinavian multicenter study of the effects of cyclosporine immunosuppression

  1987cited by this paper
• HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin.

  1986cited by this paper
• Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir.

  1985cited by this paper
• PROPHYLACTIC ORAL ACYCLOVIR AFTER RENAL TRANSPLANTATION

  1985cited by this paper
• Cyclosporine nephrotoxicity.

  1985cited by this paper
• Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.

  1985cited by this paper
• Cyclosporine-associated chronic nephropathy.

  1984cited by this paper
• Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal Allografts

  1982cited by this paper
• Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.

  1981cited by this paper
• A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

  1981cited by this paper
• Cyclosporin A in patients receiving renal allografts from cadaver donors.

  1978cited by this paper
• Report of the committee on the genetic constitution of autosomes other than chromosomes 1,2 and 6.

  1976cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Cost Evaluation of Basiliximab Treatment for Renal Transplant Patients in Japan

  2012cites this paper
• Immunosuppression in live-related donor renal transplantation.

  2001cites this paper
• A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS

  2001cites this paper
• IS GRAFT SURVIVAL AFFECTED BY AGE ?AC ASE CONTROL STUDY

  2000cites this paper
• Renal transplantation in older adults: is graft survival affected by age? A case control study.

  2000cites this paper
• A RANDOMIZED TRIAL COMPARING CYCLOSPORINE AND STEROIDS WITH CYCLOSPORINE, AZATHIOPRINE, AND STEROIDS IN CADAVERIC RENAL TRANSPLANTATION 1

  1998cites this paper
• Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation.

  1998cites this paper
• A randomized trial comparing cyclosporine and steroids with cyclosporine, azathioprine, and steroids in cadaveric renal transplantation.

  1998cites this paper
• Possibilities for therapeutic drug monitoring of azathioprine: 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells.

  1997cites this paper
• Gender differences in a kidney transplant population.

  1997cites this paper
• ISCHEMIC HEART DISEASE—MAJOR CAUSE OF DEATH AND GRAFT LOSS AFTER RENAL TRANSPLANTATION IN SCANDINAVIA

  1995cites this paper